|
WASF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6929790902509E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
4.978000E-03 |
| Normal-vs-Stage3 |
1.218580E-04 |
| Normal-vs-Stage4 |
7.020200E-04 |
| Stage1-vs-Stage2 |
2.026400E-02 |
| Stage1-vs-Stage3 |
1.772090E-04 |
| Stage1-vs-Stage4 |
1.797160E-04 |
| Stage2-vs-Stage3 |
8.434000E-01 |
| Stage2-vs-Stage4 |
7.264200E-01 |
| Stage3-vs-Stage4 |
8.428800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.6681100944993E-12 |
| Normal-vs-AfricanAmerican |
8.781700E-03 |
| Normal-vs-Asian |
1.513400E-01 |
| Caucasian-vs-AfricanAmerican |
2.124200E-01 |
| Caucasian-vs-Asian |
9.622400E-01 |
| AfricanAmerican-vs-Asian |
6.936600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.28448420975292E-13 |
| Normal-vs-Female |
2.28969998516959E-09 |
| Male-vs-Female |
6.562800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.023400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.67554858876429E-12 |
| Normal-vs-Age(61-80Yrs) |
4.63950000639812E-09 |
| Normal-vs-Age(81-100Yrs) |
4.067200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.616000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.278600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.027380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.423600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.364200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.295040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.369500E-04 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
4.78449999996577E-06 |
| Normal-vs-Grade 4 |
1.558130E-02 |
| Grade 1-vs-Grade 2 |
4.568400E-02 |
| Grade 1-vs-Grade 3 |
2.42739999999353E-05 |
| Grade 1-vs-Grade 4 |
2.900800E-03 |
| Grade 2-vs-Grade 3 |
3.23780000033302E-07 |
| Grade 2-vs-Grade 4 |
6.20430000042305E-07 |
| Grade 3-vs-Grade 4 |
3.223400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
7.807300E-04 |
| ccA subtype-vs-ccB subtype |
2.40730000378164E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.29009999641994E-08 |
| Normal-vs-N1 |
8.101800E-02 |
| N0-vs-N1 |
8.268200E-01 |
|
|
